Investment
Features
FeesSafety
Academy
More
Pluang+

Compare TJX Companies Inc (TJX) vs 22nd Century Group Inc (XXII) Price & Performance

TJX Companies IncTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

TJX Companies Inc vs 22nd Century Group Inc — how do they compare? TJX Companies Inc trades at $138.86 (market cap $152.62B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: TJX Companies Inc is far larger — about 245500× 22nd Century Group Inc's market cap, and TJX Companies Inc pays a 1.38% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TJX Companies Inc for 97 Days and 22nd Century Group Inc for 32 Days on average.

TJXXXII
Market Cap
$152.62B$621.67K
Volume
8,079,79445,625
Sector
Consumer CyclicalConsumer Staples
52-Week High
$168.41$483.00
52-Week Low
$122.84$0.80
Typical Hold Time
97 Days32 Days
Enterprise Value
$160.93B-$3.69M
Dividend Yield
1.38%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

TJX Companies Inc

TJX trades at $138.76, down slightly by 0.03% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company shows strong fundamentals, with revenue rising to $56.36B in 2025 and net income reaching $4.86B, alongside robust profitability metrics like a 62.17% ROE. Recent quarterly earnings have consistently beaten expectations, and the firm maintains a solid balance sheet with manageable debt levels.

The outlook for TJX is positive, supported by Wall Street's strong buy consensus (84.9% buy ratings) and a $174.15 price target implying 28% upside. Key risks include competitive pressures in off-price retail and sensitivity to consumer spending trends. Investor sentiment is buoyed by earnings momentum and expansion potential, though overbought technical conditions may prompt near-term volatility.

22nd Century Group Inc

22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.

While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TJX
100% Buy0% Sell
Avg holding period · 97 Days
XXII
100% Buy0% Sell
Avg holding period · 32 Days

About TJX Companies Inc

TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.

Read more on TJX →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →